Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-{'4-substituted piperazine-1-sulfonylmethylalkyl}-n-hydroxyfomamide compounds as metalloproteinase inhibitors

N-{'4-substituted piperazine-1-sulfonylmethylalkyl}-n-hydroxyfomamide compounds as metalloproteinase inhibitors

US Patent 7485644 · Granted Feb 3, 2009

Estimated economic value: $10,903,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Arginase inhibitors and methods of use thereof2025
Arginase inhibitors and methods of use thereof2025
Arginase inhibitors and methods of use thereof2024
Purinone compounds and their use in treating cancer2024
Launching applications2024
1,3,4-thiadiazole compounds and their use in treating cancer2023
Amino-triazolopyridine compounds and their use in treating cancer2023
2-(2,4,5-substituted-anilino)pyrimidine compounds2022
Arginase inhibitors and methods of use thereof2022
Amino-triazolopyridine compounds and their use in treating cancer2021
1,3,4-thiadiazole compounds and their use in treating cancer2021
2-(2,4,5-substituted-anilino)pyrimidine compounds2020